Omar Yusef Kudsi1,2, Georges Kaoukabani3, Naseem Bou-Ayash4, Kelly Vallar3, Alexandra Chudner3, Sara LaGrange3, Fahri Gokcal3. 1. Good Samaritan Medical Center, One Pearl Street, Brockton, MA, 02301, USA. omar.kudsi@tufts.edu. 2. Tufts University School of Medicine, Boston, MA, USA. omar.kudsi@tufts.edu. 3. Good Samaritan Medical Center, One Pearl Street, Brockton, MA, 02301, USA. 4. Tufts University School of Medicine, Boston, MA, USA.
Abstract
PURPOSE: The purpose of this study is to prospectively evaluate surgical and quality of life (QoL) outcomes of robotic retromuscular ventral hernia repair (rRMVHR) using a new hybrid mesh in high-risk patients. METHODS: Data was prospectively collected for patients classified as high-risk based on the modified ventral hernia working group (VHWG) grading system, who underwent rRMVHR using Synecor™ Pre hybrid mesh in a single center, between 2019 and 2020. Pre-, intra- and postoperative variables including hernia recurrence, surgical site events (SSE), hernia-specific quality of life (QoL), and financial costs were analyzed. QoL assessments were obtained from preoperative and postoperative patient visits. Kaplan-Meier survival analysis was performed to analyze the estimated recurrence-free time. RESULTS: Fifty-two high-risk patients, with a mean (±SD) age of 58.6 ± 13.7 years and BMI of 36.9 ± 6.6 kg/m2, were followed for a mean (±SD) period of 22.4 ± 7.1 months. A total of 11 (21.2%) patients experienced postoperative complications, out of which eight were SSEs, including 7 (13.5%) seromas, 1 (1.9%) hematoma, and no infections. Procedural interventions were required for 2 (3.8%) surgical site occurrences. Recurrence was seen in 1 (1.9%) patient. The estimated mean (95% confidence interval) recurrence-free time was 33 (32.3-34.5) months. Postoperative QoL assessments demonstrated significant improvements in comparison to preoperative QoL, with a minimum ∆mean (±SD) of -15.5 ± 2.2 at one month (p < 0.001). The mean (±SD) procedure cost was $13,924.18 ± 7856.95 which includes the average mesh cost ($5390.12 ± 3817.03). CONCLUSION: Our study showed favorable early and mid-term outcomes, in addition to significant improvements in QoL, after rRMVHR using Synecor™ hybrid mesh in high-risk patients.
PURPOSE: The purpose of this study is to prospectively evaluate surgical and quality of life (QoL) outcomes of robotic retromuscular ventral hernia repair (rRMVHR) using a new hybrid mesh in high-risk patients. METHODS: Data was prospectively collected for patients classified as high-risk based on the modified ventral hernia working group (VHWG) grading system, who underwent rRMVHR using Synecor™ Pre hybrid mesh in a single center, between 2019 and 2020. Pre-, intra- and postoperative variables including hernia recurrence, surgical site events (SSE), hernia-specific quality of life (QoL), and financial costs were analyzed. QoL assessments were obtained from preoperative and postoperative patient visits. Kaplan-Meier survival analysis was performed to analyze the estimated recurrence-free time. RESULTS: Fifty-two high-risk patients, with a mean (±SD) age of 58.6 ± 13.7 years and BMI of 36.9 ± 6.6 kg/m2, were followed for a mean (±SD) period of 22.4 ± 7.1 months. A total of 11 (21.2%) patients experienced postoperative complications, out of which eight were SSEs, including 7 (13.5%) seromas, 1 (1.9%) hematoma, and no infections. Procedural interventions were required for 2 (3.8%) surgical site occurrences. Recurrence was seen in 1 (1.9%) patient. The estimated mean (95% confidence interval) recurrence-free time was 33 (32.3-34.5) months. Postoperative QoL assessments demonstrated significant improvements in comparison to preoperative QoL, with a minimum ∆mean (±SD) of -15.5 ± 2.2 at one month (p < 0.001). The mean (±SD) procedure cost was $13,924.18 ± 7856.95 which includes the average mesh cost ($5390.12 ± 3817.03). CONCLUSION: Our study showed favorable early and mid-term outcomes, in addition to significant improvements in QoL, after rRMVHR using Synecor™ hybrid mesh in high-risk patients.
Authors: Filip E Muysoms; Aude Vanlander; Robrecht Ceulemans; Iris Kyle-Leinhase; Maarten Michiels; Ivo Jacobs; Pieter Pletinckx; Frederik Berrevoet Journal: Surgery Date: 2016-06-14 Impact factor: 3.982
Authors: F Muysoms; G Campanelli; G G Champault; A C DeBeaux; U A Dietz; J Jeekel; U Klinge; F Köckerling; V Mandala; A Montgomery; S Morales Conde; F Puppe; R K J Simmermacher; M Śmietański; M Miserez Journal: Hernia Date: 2012-04-18 Impact factor: 4.739
Authors: Michael J Rosen; Joel J Bauer; Marco Harmaty; Alfredo M Carbonell; William S Cobb; Brent Matthews; Matthew I Goldblatt; Don J Selzer; Benjamin K Poulose; Bibi M E Hansson; Camiel Rosman; James J Chao; Garth R Jacobsen Journal: Ann Surg Date: 2017-01 Impact factor: 12.969
Authors: F E Muysoms; M Miserez; F Berrevoet; G Campanelli; G G Champault; E Chelala; U A Dietz; H H Eker; I El Nakadi; P Hauters; M Hidalgo Pascual; A Hoeferlin; U Klinge; A Montgomery; R K J Simmermacher; M P Simons; M Smietański; C Sommeling; T Tollens; T Vierendeels; A Kingsnorth Journal: Hernia Date: 2009-06-03 Impact factor: 4.739